TY  - JOUR
AU  - Kamali, Ali N.
AU  - Hamedifar, Haleh
AU  - Eisenhut, Michael
AU  - Bautista Santa Cruz, José Manuel
PY  - 2024
DO  - 10.1177/25151355241288453
SN  - 2515-1355
UR  - https://hdl.handle.net/20.500.14352/110371
T2  - Therapeutic Advances in Vaccines and Immunotherapy
AB  - Multiple myeloma (MM), a cancer of the bone marrow, is categorized as the second most common hematological malignancy of adults in the Western world. Despite dramatic improvements in immunotherapies in the field of cancers, MM immunotherapy has not...
LA  - eng
M2  - 1
PB  - SAGE Publications Ltd
KW  - Multiple myeloma
KW  - Check point inhibitors
KW  - Immunotherapy
TI  - Multiple myeloma and the potential of new checkpoint inhibitors for immunotherapy
TY  - journal article
VL  - 12
ER  -